Focused Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-160	Closed	-$14.3K	–	991
2023 Q4	$14.3K	Sell	160 -288	-64%	-$21.4K	﹤0.01%	488
2023 Q3	$32.7K	Sell	448 -18	-4%	-$1.44K	0.01%	351
2023 Q2	$38.8K	Sell	466 -21	-4%	-$1.76K	0.01%	344
2023 Q1	$37.1K	Sell	487 -41,779	-99%	-$3.47M	0.01%	352
2022 Q4	$3.51M	Buy	42,266 +549	+1%	+$44.4K	0.71%	26
2022 Q3	$3.31M	Buy	41,717 +595	+1%	+$50.2K	0.69%	26
2022 Q2	$3.05M	Sell	41,122 -75	-0.2%	-$5.63K	0.56%	35
2022 Q1	$3.7M	Buy	41,197 +3,870	+10%	+$357K	0.59%	28
2021 Q4	$4.18M	Buy	37,327 +1,162	+3%	+$140K	0.65%	25
2021 Q3	$4.55M	Buy	36,165 +1,087	+3%	+$140K	0.74%	22
2021 Q2	$4.75M	Buy	35,078 +2,676	+8%	+$352K	0.79%	22
2021 Q1	$4.39M	Sell	32,402 -3,969	-11%	-$594K	0.78%	20
2020 Q4	$5.12M	Buy	36,371 +261	+0.7%	+$33.4K	1%	16
2020 Q3	$4.02M	Buy	36,110 +549	+2%	+$61.5K	0.88%	17
2020 Q2	$3.98M	Buy	35,561 +1,383	+4%	+$136K	0.93%	17
2020 Q1	$2.65M	Buy	34,178 +34,114	+53,303%	+$3.02M	0.76%	19
2019 Q4	$6K	Buy	+64	New	+$5.54K	﹤0.01%	563